$0.608000
-0.01-2.25%
At close: -
$0.605100
-0.0029-0.48%
After Hours: 9:14 AM EDT
Comments
Loading...
Protagenic Therapeutics (PTIX) Forecast
NewsEarningsProtagenic Therapeutics (PTIX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestProtagenic Therapeutics (NASDAQ:PTIX) Stock Quotes, Forecast and News Summary
Protagenic Therapeutics Stock (NASDAQ: PTIX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Protagenic Therapeutics (PTIX) stock?
You can purchase shares of Protagenic Therapeutics (NASDAQ:PTIX) through any online brokerage.
Who are Protagenic Therapeutics (PTIX) competitors?
Other companies in Protagenic Therapeutics’s space includes: Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Palisade Bio (NASDAQ:PALI), Portage Biotech (NASDAQ:PRTG) and AquaBounty Techs (NASDAQ:AQB).
What is the forecast, or price target, for Protagenic Therapeutics (PTIX) stock?
There is no analysis for Protagenic Therapeutics to provide a consensus price target.
What is the current price for Protagenic Therapeutics (PTIX)?
The stock price for Protagenic Therapeutics (NASDAQ: PTIX) is $0.6051 last updated November 21, 2024 at 9:14 AM EST.
Does Protagenic Therapeutics (PTIX) pay a dividend?
There are no upcoming dividends for Protagenic Therapeutics.
When is Protagenic Therapeutics (NASDAQ:PTIX) reporting earnings?
Protagenic Therapeutics’s Q3 earnings are confirmed for Thursday, November 14, 2024.
Is Protagenic Therapeutics (PTIX) going to split?
There is no upcoming split for Protagenic Therapeutics.
What sector and industry does Protagenic Therapeutics (PTIX) operate in?
Protagenic Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.